Apr 19, 2007 by Ryan FuhrmannDueling Fools: Wal-Mart Bull RebuttalHooray for that sluggish stock price!
Apr 18, 2007 by Ryan FuhrmannMarshall & Ilsley Brace for Split: Fool by NumbersFast facts the Fool way.
Apr 18, 2007 by Ryan FuhrmannBulking Up by Slimming DownMarshall & Ilsley gets set to drop Metavante from the corporate fold.
Apr 18, 2007 by Ryan FuhrmannNo Interest in Inversion at Wells FargoNet interest margin trends highlight why Wells Fargo is an industry leader.
Apr 18, 2007 by Ryan FuhrmannWhat's in the Wind?Investing in wind power isn't all that easy, especially for Americans.
Apr 18, 2007 by Ryan FuhrmannHealthy Prognosis at Johnson & JohnsonThe long-term prognosis for JNJ remains healthy.
Apr 18, 2007 by Ryan FuhrmannSitting Pretty at Regions FinancialAlabama-based financial institution is increasing its clout in appealing Sunbelt states.
Apr 17, 2007 by Ryan FuhrmannKrispy Kreme Is Sweet No MoreBuyers' appetite for these doughnuts continues to wane.
Apr 17, 2007 by Ryan FuhrmannDiversification Pays at Wachovia: Fool by NumbersFast facts the Fool way.
Apr 17, 2007 by Ryan FuhrmannA Golden Opportunity for WachoviaWill its far-reaching services help the bank keep rewarding investors?
Apr 17, 2007 by Ryan FuhrmannClean Bill of Health at Eli LillyLilly recorded another solid quarter, but its valuation is a little rich.
Apr 13, 2007 by Ryan FuhrmannThe Bed Bath Debate ContinuesIs a lowered stock multiple enough to offset Bed Bath's flagging growth?
Apr 13, 2007 by Ryan FuhrmannSink or Swim at Pier 1Is time running out for Pier 1 to improve its sales?
Apr 13, 2007 by Ryan FuhrmannRite Aid's Right-Size AmbitionsThe chain's potential has so far gone unrealized.
Apr 13, 2007 by Ryan FuhrmannWear a Helmet With PolarisPolaris has near-term challenges but could ride high over time.
Apr 13, 2007 by Ryan FuhrmannLess Sugar-Coating Needed at Krispy Kreme: Fool by NumbersFast facts the Fool way.
